Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on October 24, 2018, regarding events occurring on October 23 and October 24, 2018. The filing details the completion of a private placement of convertible senior notes.
Key Financial Metrics
The filing reports the issuance of debt securities rather than operational financial results. Key metrics include:
- Debt Issuance: $22.5 million aggregate principal amount of 1.50% Convertible Senior Notes due 2025.
- Total Offering Size: Combined with the initial $150.0 million issuance on October 22, 2018, the total principal amount of notes issued is $172.5 million.
- Interest Rate: 1.50% per annum.
- Maturity Date: 2025.
- Revenue, Profit, Cash Flow, Margins, Liquidity: The filing text does not provide a clear value for these operational metrics.
Material Changes
The primary material change is the full exercise of an option by the purchasers (J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC) to acquire an additional $22.5 million of notes. This action increased the total capital raised through this specific convertible note offering.
Outlook, Risks, and Unusual Items
Management Commentary: The Company completed the sale of the Additional Notes pursuant to the Indenture dated October 22, 2018. The terms of the Additional Notes are identical to the initial notes issued on October 22, 2018.
Risks and Contingencies: The notes and any Class A common stock issuable upon conversion are not registered under the Securities Act. Consequently, they may not be offered or sold in the United States unless registered or an exemption applies.
Investor Verification Checklist
- Verify the total outstanding principal of the 1.50% Convertible Senior Notes due 2025 ($172.5 million).
- Review the full text of the Indenture (Exhibit 4.1) and Form of Note (Exhibit 4.2) filed on October 22, 2018, for conversion terms and covenants.
- Confirm the use of proceeds from the $172.5 million offering as disclosed in the October 22, 2018 filing.
- Monitor future filings for any registration statements regarding the conversion of these notes into common stock.